Xcopri Interactions
There are 578 drugs known to interact with Xcopri (cenobamate), along with 4 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 84 are major, 460 are moderate, and 34 are minor.
- View all 578 medications that may interact with Xcopri
- View Xcopri alcohol/food interactions (1)
- View Xcopri disease interactions (4)
Most frequently checked interactions
View interaction reports for Xcopri (cenobamate) and the medicines listed below.
- albuterol
- atorvastatin
- Briviact (brivaracetam)
- clobazam
- clonazepam
- Epidiolex (cannabidiol)
- famotidine
- folic acid
- Fycompa (perampanel)
- gabapentin
- ibuprofen
- Keppra (levetiracetam)
- lacosamide
- Lamictal (lamotrigine)
- lamotrigine
- levetiracetam
- levothyroxine
- Lexapro (escitalopram)
- lorazepam
- melatonin
- multivitamin
- Nayzilam (midazolam)
- omeprazole
- Onfi (clobazam)
- topiramate
- trazodone
- Vimpat (lacosamide)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
- zonisamide
Xcopri alcohol/food interactions
There is 1 alcohol/food interaction with Xcopri (cenobamate).
Xcopri disease interactions
There are 4 disease interactions with Xcopri (cenobamate) which include:
More about Xcopri (cenobamate)
- Xcopri consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (37)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: carbamate anticonvulsants
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.